Terms & Conditions

Welcome to the official website of OncoDiscover, a product of Actorius Innovations & Research Pvt. Ltd., accessible at [https://oncodiscover.com] (the “Website”). By accessing or using this Website, you agree to comply with and be bound by the following Terms and Conditions. Please review them carefully.

​

1. Acceptance of Terms
By accessing, browsing, or using this Website, you acknowledge that you have read, understood, and agreed to be bound by these Terms and Conditions, along with our Privacy Policy. If you do not agree with any part of these terms, you must discontinue use of the Website immediately.

​

2. Use of the Website
The content on this Website is provided for general informational and educational purposes only and is subject to change without prior notice. You agree to use this Website solely for lawful purposes and in a manner that does not infringe the rights of, restrict, or inhibit the use of this Website by any third party.

Any unauthorised use, misuse, or abuse of this Website may give rise to a claim for damages and/or be a criminal offence under applicable Indian laws.

​

3. Intellectual Property Rights
All content on this Website, including but not limited to the OncoDiscover brand, text, graphics, logos, icons, images, illustrations, videos, audio, software, design elements, and data compilations, is the property of Actorius Innovations & Research Pvt. Ltd. or its licensors and is protected by applicable Indian and international intellectual property laws.

You may not copy, reproduce, modify, republish, upload, post, transmit, distribute, or exploit any content from this Website in any form or by any means without prior written permission from Actorius Innovations & Research Pvt. Ltd.

​

4. Third-Party Links
This Website may contain links to third-party websites or resources provided for convenience or informational purposes only. Such links do not constitute an endorsement, sponsorship, or recommendation by Actorius Innovations & Research Pvt. Ltd. or OncoDiscover.

We have no control over the content, policies, or practices of third-party websites and accept no responsibility or liability for any loss or damage arising from your use of such websites.

​

5. Disclaimer of Warranties and Limitation of Liability
This Website and its content are provided on an “as is” and “as available” basis. Actorius Innovations & Research Pvt. Ltd. makes no representations or warranties, express or implied, regarding the accuracy, completeness, reliability, suitability, or availability of the OncoDiscover Website or its content.

To the fullest extent permitted by law, Actorius Innovations & Research Pvt. Ltd. shall not be liable for any direct, indirect, incidental, special, consequential, or exemplary damages, including but not limited to loss of profits, data, goodwill, or other intangible losses, arising out of or in connection with your use of, or inability to use, the Website.

Nothing in these Terms shall exclude or limit any liability that cannot be excluded under applicable Indian law.

​

6. Indemnification
You agree to indemnify, defend, and hold harmless Actorius Innovations & Research Pvt. Ltd., its directors, officers, employees, affiliates, partners, agents, and licensors from and against any claims, liabilities, damages, losses, costs, or expenses (including reasonable legal fees) arising from:

• Your use or misuse of the Website

• Your violation of these Terms and Conditions

• Your infringement of any intellectual property or other rights of any third party

​

7. Governing Law and Jurisdiction
These Terms and Conditions shall be governed by and construed in accordance with the laws of India. You agree that any disputes arising out of or relating to these Terms or the use of the Website shall be subject to the exclusive jurisdiction of the courts located in [India – Pune, Maharashtra].

​

8. Modifications to Terms
Actorius Innovations & Research Pvt. Ltd. reserves the right to revise, modify, or update these Terms and Conditions at any time without prior notice. Any changes will be effective immediately upon posting on the Website. Your continued use of the Website after such changes constitutes acceptance of the revised Terms.

​

9. Services, Refunds, and Cancellations

OncoDiscover services offered by Actorius Innovations & Research Pvt. Ltd., including laboratory testing, diagnostics, analytics, research services, and related scientific and healthcare solutions, are subject to the terms communicated at the time of booking, registration, or engagement.

​

A test booking shall be considered confirmed only after successful payment verification and acceptance by Actorius Innovations & Research Pvt. Ltd. Submission of a booking request or payment does not automatically guarantee test processing or sample collection.

Cancellation requests may be submitted before sample collection has been completed. Once sample collection has been performed, laboratory processing has commenced, analytical work has begun, or any portion of the service has been rendered, cancellations may not be permitted and refunds may not be available.

​

Due to the specialized, scientific, and personalized nature of our services, refunds are generally not available for completed sample collections, processed samples, completed analyses, generated reports, or partially rendered services. However, refund requests may be considered in exceptional circumstances at the sole discretion of Actorius Innovations & Research Pvt. Ltd.

​

If a test cannot be performed due to operational, technical, regulatory, logistical, or sample-related reasons attributable to Actorius Innovations & Research Pvt. Ltd., the company may, at its discretion, offer a re-test, rescheduling of sample collection, service credit, partial refund, or full refund, as deemed appropriate.

​

All requests for cancellations, refunds, or related service concerns must be submitted in writing through the company's official communication channels. Each request will be reviewed on a case-by-case basis, and the company's decision shall be final, subject to applicable laws and regulations.

​

Actorius Innovations & Research Pvt. Ltd. reserves the right to modify its refund, cancellation, and service policies from time to time without prior notice, provided such changes do not affect services already completed.

​

10. OncoDiscover® Test Booking Terms, Conditions, and Consents

By booking an OncoDiscover® test through our Website, you acknowledge, understand, and agree to the following terms and conditions:

​

10.1 Test Booking and Eligibility

The OncoDiscover® test is offered subject to the availability of services, verification of submitted information, and successful sample collection. Submission of a booking request or payment does not guarantee acceptance of the test request. Actorius Innovations & Research Pvt. Ltd. reserves the right to review, verify, and accept or decline a booking based on operational, medical, technical, or regulatory considerations.

​

10.2 Payment Verification

Actorius Innovations & Research Pvt. Ltd. may require verification of payment before proceeding with sample collection or test processing. Patients may be requested to provide payment confirmation emails, transaction records, receipts, or other supporting documentation for verification purposes.

​

10.3 Medical Records and Documentation

Where requested, patients are required to provide relevant medical records, pathology reports, treatment history, or other supporting clinical documents necessary for test evaluation and processing. Failure to provide requested documentation may result in delays or inability to process the test.

​

10.4 Sample Collection

Sample collection will be scheduled only after successful verification of booking details, payment, and any required documentation. Patients agree to cooperate with authorized personnel for sample collection and provide accurate information during the process.

​

10.5 Turnaround Time (TAT)

The estimated turnaround time for the OncoDiscover® test is 7–10 working days from the date the sample is received and accepted for processing by our laboratory.

The turnaround time is an estimate only and may vary due to technical, operational, logistical, quality control, regulatory, or other unforeseen circumstances. Actorius Innovations & Research Pvt. Ltd. reserves the right to extend the turnaround time where necessary. In the event of a significant delay, the patient will be informed using the contact details provided during registration.

​

10.6 Sample Quality and Processing

Test results are dependent on the quality, condition, integrity, and suitability of the submitted sample. Actorius Innovations & Research Pvt. Ltd. reserves the right to reject, request recollection, or delay processing of samples that do not meet quality requirements.

​

10.7 Test Results and Interpretation

The OncoDiscover® test is intended to support clinical decision-making and should not be interpreted as a standalone diagnostic conclusion. Test results must always be reviewed and interpreted by qualified healthcare professionals in conjunction with clinical findings, medical history, and other diagnostic information.

​

10.8 Research Use of Samples

Subject to applicable laws, regulations, ethical approvals, and patient consent, collected samples and associated anonymized data may be stored and utilized for clinical research, scientific validation, product improvement, and related research activities.

​

10.9 Cancellation and Refunds

Once sample collection has been completed, laboratory processing has commenced, or analytical work has begun, cancellations and refunds may not be available. Any refund or cancellation requests will be evaluated at the sole discretion of Actorius Innovations & Research Pvt. Ltd. in accordance with applicable policies.

​

10.10 Patient Consents

By booking the OncoDiscover® test and accepting these Terms and Conditions, you confirm and consent that:​'

​

- I have read and understood the information provided regarding the OncoDiscover® test and voluntarily consent to provide my blood sample for testing.

- I consent to the storage and use of my sample and associated anonymized data for clinical research, scientific validation, product development, and related applications, where permitted by law and applicable ethical requirements.

- I understand that test results depend on sample quality, technical limitations, analytical methodologies, and other factors, and that results should be interpreted in conjunction with clinical findings by qualified healthcare professionals.

- I confirm that Actorius Innovations & Research Pvt. Ltd. has provided sufficient information regarding the test, sample collection process, expected turnaround time, and associated requirements.

- I confirm that the information and documents provided by me are true, accurate, and complete to the best of my knowledge.

- I agree to cooperate with Actorius Innovations & Research Pvt. Ltd., its representatives, laboratory personnel, and authorized sample collection partners as required for the completion of the testing process.

- I acknowledge and agree that the stated turnaround time is an estimate and may be revised at the sole discretion of Actorius Innovations & Research Pvt. Ltd. based on operational, technical, or quality-related requirements.

- I confirm that the payment has been made by me or on my behalf and agree to provide payment verification documents if requested by the company.

- I have read, understood, and agree to the Company Policies, Privacy Policy, Terms of Use, test details, requirements, and all consents contained herein.

 

10.11 Sample Collection Requirements

To ensure accurate testing and reliable results, patients acknowledge and agree to the following sample collection requirements:

​

- Blood samples should preferably be collected at least seven (7) days after the last chemotherapy or radiation therapy session unless otherwise advised by the treating physician.
- Samples must be collected in a K2-EDTA blood collection tube (purple-capped vacutainer).
- The recommended blood volume is 10 mL.
- Samples must be collected from peripheral whole blood.
- Blood collection must be performed by a trained healthcare professional, phlebotomist, laboratory technician, or authorized collection personnel.
- Following collection, the sample tube should be gently inverted as recommended to ensure proper mixing with the anticoagulant.
- Samples should be stored and transported under recommended conditions, generally between 2°C and 8°C, unless otherwise specified by Actorius Innovations & Research Pvt. Ltd.
- Samples should be shipped to the designated laboratory within the recommended timeframe following collection.
- Sample stability and acceptance are subject to laboratory quality requirements.

 

10.12 Sample Rejection Criteria

Actorius Innovations & Research Pvt. Ltd. reserves the right to reject samples that do not meet quality or handling requirements, including but not limited to:

​

- Insufficient blood volume.
- Clotted or aggregated blood samples.
- Frozen or improperly stored samples.
- Incorrect, incomplete, or missing patient identification labels.
- Leaked, damaged, contaminated, or broken collection containers.
- Improper packaging, storage, transportation, or delayed shipment.
- Any condition that may compromise test accuracy, reliability, or sample integrity.

Where feasible, a repeat sample collection may be requested.

 

10.13 Clinical Significance and Interpretation of Results

The OncoDiscover® Circulating Tumor Cell (CTC) Test is intended to detect and enumerate circulating tumor cells and associated biomarkers in peripheral blood, as applicable to the specific test ordered.

​

Patients acknowledge and understand that:

​

- The test is designed to provide clinically relevant information that may assist physicians in evaluating disease status, prognosis, treatment monitoring, and related clinical considerations.
- The presence, absence, quantity, or characteristics of circulating tumor cells and associated biomarkers should not be interpreted in isolation and must be considered together with clinical findings, medical history, imaging studies, pathology results, and other diagnostic information.
- Certain biomarkers evaluated through circulating tumor cells, including but not limited to PD-L1 and HER2 where applicable, may provide clinically relevant information; however, such measurements may not constitute standardized diagnostic assessments and require physician interpretation.
- Scientific understanding of circulating tumor cells and related biomarkers continues to evolve, and future advances may further refine interpretation of test findings.

​

10.14 Diagnostic Limitations

The patient acknowledges and agrees that:

​

- The OncoDiscover® test is intended as an adjunctive clinical tool and is not a standalone diagnostic test.
- Test results alone shall not be used as the sole basis for diagnosis, treatment decisions, or clinical management.
- A negative result does not completely exclude the presence of disease, recurrence, progression, or metastasis.
- A positive result may require additional clinical evaluation, imaging, pathology review, laboratory investigations, or physician assessment for confirmation and interpretation.
- No laboratory test can guarantee absolute accuracy, and results are subject to biological variability, sample quality, technical limitations, and scientific constraints.

​

10.15 Patient Acknowledgement

By proceeding with the booking, sample collection, and testing process, I acknowledge that I have read, understood, and accepted the sample collection requirements, sample rejection criteria, clinical significance statements, diagnostic limitations, and all other terms, conditions, and consents applicable to the OncoDiscover® test.
 

​

11. Contact Information
If you have any questions, concerns, or requests regarding these Terms and Conditions, please contact us at:

​

OncoDiscover
(A product of Actorius Innovations & Research Pvt. Ltd.)

​

Website: https://actorius.com/contact

Email: info@actorius.com